NYX-104

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameNYX-104
Drug Alias NameNYX-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 3 antagonists
TargetsShort transient receptor potential channel 3
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoxopharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNoxopharm Ltd
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A